Preprint Article Version 1 This version is not peer-reviewed

Appropriateness of Ketoanalogues of Aminoacids, Calcium Citrate, and Inulin Supplementation for CKD Management: A RAND/UCLA Consensus

Version 1 : Received: 9 August 2024 / Approved: 12 August 2024 / Online: 12 August 2024 (10:26:41 CEST)

How to cite: Saavedra-Fuentes, N.; Carmona-Montesinos, E.; Castañeda-Hernández, G.; Campos, I.; Castillo-Salinas, J. C.; Castillo-Tapia, J. A.; Del Castillo-Loreto, K. G.; Falcón-Martínez, J. C.; Fuentes-García, R.; Guerrero, M. Á. G. D. L.; García-García, V.; Gómez-García, E. F.; González-Toledo, R.; Jaime, A.; Rely, K.; Lerma, C.; Morales-Buenrostro, L. E.; Quilantan-Rodriguez, M.; Rodriguez-Matías, A.; Rojas-Rodriguez, F. O.; Valdez-Ortiz, R.; Wasung, M.; Ceron-Trujullo, B.; Ramirez-Ramirez, E. Appropriateness of Ketoanalogues of Aminoacids, Calcium Citrate, and Inulin Supplementation for CKD Management: A RAND/UCLA Consensus. Preprints 2024, 2024080782. https://doi.org/10.20944/preprints202408.0782.v1 Saavedra-Fuentes, N.; Carmona-Montesinos, E.; Castañeda-Hernández, G.; Campos, I.; Castillo-Salinas, J. C.; Castillo-Tapia, J. A.; Del Castillo-Loreto, K. G.; Falcón-Martínez, J. C.; Fuentes-García, R.; Guerrero, M. Á. G. D. L.; García-García, V.; Gómez-García, E. F.; González-Toledo, R.; Jaime, A.; Rely, K.; Lerma, C.; Morales-Buenrostro, L. E.; Quilantan-Rodriguez, M.; Rodriguez-Matías, A.; Rojas-Rodriguez, F. O.; Valdez-Ortiz, R.; Wasung, M.; Ceron-Trujullo, B.; Ramirez-Ramirez, E. Appropriateness of Ketoanalogues of Aminoacids, Calcium Citrate, and Inulin Supplementation for CKD Management: A RAND/UCLA Consensus. Preprints 2024, 2024080782. https://doi.org/10.20944/preprints202408.0782.v1

Abstract

Background: Current treatment for Chronic Kidney Disease (CKD) focuses on improving manifestations and delaying progression. Nutritional approaches play a crucial role in CKD management, and various supplements have become available. Ketoanalogues of amino acids (KA), calcum citrate, and inulin have been proposed as suitable supplements, yet their widespread use has been limited due to insufficient evidence. This study aimed to generate general guidance statements on the appropriateness of these supplements through a RAND/UCLA consensus process; Methods: A RAND/UCLA consensus panel was convened to evaluate the appropriateness of these supplements in different clinical scenarios. In this study, we present a subgroup analysis focusing on a panel of eleven clinical nephrologists from among the experts; Results: Supplementation of low protein diets (LPD) and very low protein diets (VLPD) with KA was considered appropriate to reduce manifestations and delay CKD outcomes, supplementation with calcium citrate is considered appropriate to reduce CKD manifestations, and supplementation with inulin is considered appropriate to delay CKD outcomes and manage comorbidities; Conclusions: Based on a combination of clinical experience and scientific evidence , the panel reached a consensus that KA supplementation of LPD and VLPD, calcium citrate, and inulin are appropriate in patients with CKD across various scenarios.

Keywords

ketoanalogues of amino acids; inulin; calcium citrate; consensus; chronic kidney disease; supplementation

Subject

Medicine and Pharmacology, Urology and Nephrology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.